Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP324250.RAN3vVoirJyXcuwKxDB4_8zo6sIBRuP2yp87IkZe8hw9g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP324250.RAN3vVoirJyXcuwKxDB4_8zo6sIBRuP2yp87IkZe8hw9g130_assertion type Assertion NP324250.RAN3vVoirJyXcuwKxDB4_8zo6sIBRuP2yp87IkZe8hw9g130_head.
- NP324250.RAN3vVoirJyXcuwKxDB4_8zo6sIBRuP2yp87IkZe8hw9g130_assertion description "[In this review of HER-2/neu expression in esophageal squamous cell carcinoma and adenocarcinomas of the esophagus, stomach, and colon, a wide range of expression of HER-2/neu from 0 to 83% likely reflects both differences in methods and reagents, as well as study bias associated with patient selection (i.e., early versus advanced disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324250.RAN3vVoirJyXcuwKxDB4_8zo6sIBRuP2yp87IkZe8hw9g130_provenance.
- NP324250.RAN3vVoirJyXcuwKxDB4_8zo6sIBRuP2yp87IkZe8hw9g130_assertion evidence source_evidence_literature NP324250.RAN3vVoirJyXcuwKxDB4_8zo6sIBRuP2yp87IkZe8hw9g130_provenance.
- NP324250.RAN3vVoirJyXcuwKxDB4_8zo6sIBRuP2yp87IkZe8hw9g130_assertion SIO_000772 11458821 NP324250.RAN3vVoirJyXcuwKxDB4_8zo6sIBRuP2yp87IkZe8hw9g130_provenance.
- NP324250.RAN3vVoirJyXcuwKxDB4_8zo6sIBRuP2yp87IkZe8hw9g130_assertion wasDerivedFrom befree-2016 NP324250.RAN3vVoirJyXcuwKxDB4_8zo6sIBRuP2yp87IkZe8hw9g130_provenance.
- NP324250.RAN3vVoirJyXcuwKxDB4_8zo6sIBRuP2yp87IkZe8hw9g130_assertion wasGeneratedBy ECO_0000203 NP324250.RAN3vVoirJyXcuwKxDB4_8zo6sIBRuP2yp87IkZe8hw9g130_provenance.